Source: Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Carmen Pérez-Olivares, Teresa Segura de la Cal, Ángela Flox-Camacho, Jorge Nuche, Jair Tenorio, Amaya Martínez Meñaca, Alejandro Cruz-Utrilla, Javier de la Cruz-Bertolo, Marte Pérez Núñez, Spanish PAH Consortium, Fernando Arribas-Ynsaurriaga, Pilar Escribano Subías. The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease. Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021

Member's Comments

No comment yet.

Related content which might interest you: The role of cardiopulmonary exercise tests in pulmonary arterial hypertension Source: Eur Respir Rev, 27 (148) 170134; 10.1183/16000617.0134-2017 Year: 2018 Cardiopulmonary exercise test to predict pulmonary rehabilitation outcome in chronic obstructive pulmonary disease (COPD) Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017 The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Physiological responses to cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006 Cardiopulmonary exercise testing for detection of early pulmonary vascular changes in relatives of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Cardiopulmonary exercise testing in patients with severe pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 489s Year: 2001 Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Distinguishing pulmonary hypertension in interstitial lung disease by ventilation and perfusion defects as measured by cardiopulmonary exercise testing Source: Annual Congress 2012 - Exercise testing in disease Year: 2012 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 CPET in pulmonary vascular disease Source: ERS Skills course - Clinical exercise testing: advanced Year: 2018 Pulmonary function and cardiopulmonary exercise tests in patients with bronchiectasis Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010 Patterns of cardiopulmonary response to exercise in pulmonary vascular diseases Source: Eur Respir Monogr 2018; 80: 160-174 Year: 2018 The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing Year: 2011 Gas exchange abnormality during cardiopulmonary exercise test in patients with primary pulmonary hypertension Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 Cardiopulmonary exercise testing, six minute walk and hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Early histological changes of pulmonary arterial hypertension disclosed by invasive cardiopulmonary exercise testing Source: International Congress 2019 – CCC Pulmonary vascular diseases Year: 2019 Physiological responses in the cardiopulmonary exercise test to arm and leg in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 The role of cardiopulmonary exercise testing in assessment of the severity of patients with PAH associated with congenital heart disease. Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019